BACE1 and Alzheimer disease: This article reviews recent advances in this field, which demonstrate (1) distinct functions and mechanisms underlying ALF and classic hippocampal amnesia in AD continuum and (2) the utility of ALF and its potential biomarkers in optimal design of next-generation BACE1 inhibitor trials at preclinical AD stages.